INLUENCE OF OSTEOPOROSIS AND ITS CAUSATIVE FACTORS ON THE PREVENTION OF RECURRENCE OF URINARY STONE DISEASE
- Authors: Demidko L.S1, Rudenko V.I1, Fadeev V.V1, Demidko Y.L1, Amosov A.V1, Kuz’micheva G.M2, Grigoryan V.A1, Enikeev M.E1, Amosova M.V1
-
Affiliations:
- FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
- Physicotechnological institute “MIREA-Russian technological university”
- Issue: No 4 (2019)
- Pages: 26-31
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312220
- DOI: https://doi.org/10.18565/urology.2019.4.26-31
- ID: 312220
Cite item
Abstract
Full Text
About the authors
L. S Demidko
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: klubnika47@yandex.ru
Ph.D. student, Institute for Urology and Human Reproductive Health Moscow, Russia
V. I Rudenko
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: rudenko-vadim@rambler.ru
MD, professor Moscow, Russia
V. V Fadeev
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: thyroclin@gmail.com
corresponding member of RAS, professor, MD, Head of the Department of Endocrinology Moscow, Russia
Yu. L Demidko
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: demidko1@mail.ru
MD, physician at the Institute for Urology and Human Reproductive Health Moscow, Russia
A. V Amosov
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: amosov-av@yandex.ru
MD, professor at the Institute for Urology and Human Reproductive Health Moscow, Russia
G. M Kuz’micheva
Physicotechnological institute “MIREA-Russian technological university”
Email: galina_kuzmicheva@list.ru
Doctor of Chemical Science, professor, Department of Physics and Chemistry of Materials named after B.A. Dogadkin Moscow, Russia
V. A Grigoryan
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: doctor-grigoryan@mail.ru
MD, professor at the Institute for Urology and Human Reproductive Health Moscow, Russia
M. E Enikeev
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: enikmic@mail.ru
MD, professor at the Institute for Urology and Human Reproductive Health Moscow, Russia
M. V Amosova
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia
Email: amosov-av@yandex.ru
Ph.D. student at the Department of Endocrinology Moscow, Russia
References
- Rudenko V.I.,SemenyakinI.V.,Malhasyan V.A., Gadjiev N.K. Russian clinical guidelines. Urinary stone disease. Urology. 2017;2(Supplement):30-63.
- Türk C., Neisius A., Petrik A., Seitz C., Skolarikos A., Tepeler A., Thomas K. EAU Guidelines. 2017.
- Arrabal-Marti'n M., Cano-Garci'a M.C., Arrabal-Polo M.Á., Domínguez-Amillo A., Canales-Casco N., de la Torre-Trillo J., Cózar-Olmo J.M. Etiopathogenic factors of the different types of urinary litiasis. Arch Esp Urol. 2017;70(1):40-50.
- TaylorE.N., Feskanich D., Paik J.M., Curhan G.C. Nephrolithiasis and Risk of Incident Bone Fracture. J Urol. 2016;195(5):1482-1486.
- Yasui T., Okada A., Hamamoto S., Ando R., Taguchi K., Tozawa K., Kohri K. Pathophysiology-based treatment of urolithiasis. Int J Urol. 2017;24(1)32-38.
- Kozyrakis D., Paridis D., Karatzas A., Soukias G., Dailiana Z. Do Calcium Supplements Predispose to Urolithiasis? Curr Urol Rep. 2017;18(3):17.
- Leslie S.W., TanejaA. Hypercalciuria. StatPearls Publishing, 2018.
- Glezer M.G. Diuretics. M.: Interbuk, 1993. Russian (Глезер М.Г. Диуретики. М.: Интербук, 1993).
- Isakova T., Anderson C.A., LeonardM.B., XieD., Gutiérrez O.M., Rosen L.K., Theurer J., Bellovich K., Steigerwalt S.P., TangI.,Anderson A.H., Townsend R.R, He J., Feldman H.I., Wolf M. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant. 2011;26(4):1258-1265.
- Ceylan K., Topal C., Erkoc R., Sayarlioglu H., Can S., Yilmaz Y., Dogan E., Algun E., Gonulalan H. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother. 2005;39(6):1034-1038.
- Favus M.J., Coe F.L. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980;53:265-271.
- US National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. 2010.
- WHO Scientific Group on the Prevention and Management of Osteoporosis. report of a WHO scientific group (WHO Technical Report series;921). Geneva. 2000.
- Benevolenskaya L.I., Lesnyak O.M. Osteoporosis. Diagnosis, prevention and treatment. M.: GEOTAR-Media 2005.
- MedCalc Statistical Software version 17.0.4: (MedCalc Software bvba, Ostend, Belgium; https://www.medcalc.org; 2017), 2017.